Viewing Study NCT06439433


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-30 @ 4:42 PM
Study NCT ID: NCT06439433
Status: COMPLETED
Last Update Posted: 2024-06-03
First Post: 2024-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ALA-PDT in Patients With CIN2 in p16-positivity and High-risk HPV Infection
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-05-31
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-20
Primary Completion Date Type: ACTUAL
Completion Date: 2024-03-06
Completion Date Type: ACTUAL
First Submit Date: 2024-05-28
First Submit QC Date: None
Study First Post Date: 2024-06-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-28
Last Update Post Date: 2024-06-03
Last Update Post Date Type: ACTUAL